Molecular Insight Pharmaceuticals, Inc.Cambridge, MA, United States (NASDAQ (GM): MIPI)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Molecular Insight Financial Statements

Molecular Insight Financial Information

Company Type Public
Headquarters
Fiscal Year-End December
Investor Relations Company Web Site
Edgar Online logo
This data is provided as per license from EDGAR Online

Molecular Insight Income Statement

  2007 2006 2005
Revenue ($ mil.) 0.7 0.3 1.2
Gross Profit ($ mil.) -- (16.3) --
Operating Income ($ mil.) (57.7) (26.5) (18.6)
Total Net Income ($ mil.) (59.8) (27.3) (18.3)
Diluted EPS (Net Income) (2.65) (7.18) (5.30)
More Molecular Insight financial information

Molecular Insight Stock Quote & Chart

10/13/08 14:19:34 EST • NASDAQ • 5.41 • Increased by +0.5700 • Increased by +11.7769 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

Molecular Insight Financial Ratios

  Company Industry
Median		 Market
Median1
Price/Sales Ratio 316.54 3.21 1.43
Price/Earnings Ratio -- 14.06 14.92
Price/Book Ratio -- 2.53 1.39
Price/Cash Flow Ratio -- 12.12 8.96
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed Molecular Insight Financial Ratios

Molecular Insight Competitive Intelligence

Bristol-Myers Squibb Covidien GE Healthcare Bio-Sciences
Annual Sales ($ mil.) 19,348.0 10,170.0 193.5
Employees 42,000 43,800 1,736
Market Cap ($ mil.) 40,802.6 26,861.4 --

Competitive Landscape